Dr Reddy's Laboratories ROE 2006-2018 | RDY

Current and historical return on equity (ROE) values for Dr Reddy's Laboratories (RDY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Dr Reddy's Laboratories ROE for the three months ending September 30, 2018 was 13.14%.
Dr Reddy's Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.24B $1.81B 12.48%
2018-06-30 $0.21B $1.91B 10.93%
2018-03-31 $0.15B $1.94B 7.89%
2017-12-31 $0.16B $1.94B 8.34%
2017-09-30 $0.18B $1.87B 9.42%
2017-06-30 $0.18B $1.91B 9.60%
2017-03-31 $0.19B $1.91B 10.46%
2016-12-31 $0.14B $1.78B 7.68%
2016-09-30 $0.16B $1.73B 8.55%
2016-06-30 $0.22B $1.69B 12.01%
2016-03-31 $0.30B $1.94B 15.88%
2015-12-31 $0.38B $1.94B 20.39%
2015-09-30 $0.38B $1.86B 21.34%
2015-06-30 $0.37B $1.87B 21.09%
2015-03-31 $0.36B $1.79B 21.55%
2014-12-31 $0.36B $1.67B 22.28%
2014-09-30 $0.37B $1.60B 23.94%
2014-06-30 $0.38B $1.61B 26.59%
2014-03-31 $0.35B $1.51B 26.02%
2013-12-31 $0.38B $1.38B 28.79%
2013-09-30 $0.35B $1.25B 27.14%
2013-06-30 $0.31B $1.26B 24.81%
2013-03-31 $0.31B $1.34B 25.68%
2012-12-31 $0.27B $1.24B 23.66%
2012-09-30 $0.30B $1.19B 27.60%
2012-06-30 $0.29B $1.07B 27.67%
2012-03-31 $0.29B $1.13B 27.43%
2011-12-31 $0.29B $0.98B 28.76%
2011-09-30 $0.26B $0.98B 24.67%
2011-06-30 $0.26B $1.10B 24.81%
2011-03-31 $0.25B $1.03B 24.20%
2010-12-31 $0.21B $1.07B 20.85%
2010-09-30 $0.03B $0.97B 3.61%
2010-06-30 $0.02B $0.97B 1.60%
2010-03-31 $0.02B $0.96B 2.26%
2009-12-31 $-0.21B $0.87B -23.21%
2009-09-30 $-0.06B $0.95B -5.93%
2009-06-30 $-0.08B $0.94B -7.69%
2009-03-31 $-0.10B $0.83B -9.24%
2008-12-31 $0.12B $1.07B 11.03%
2008-09-30 $0.06B $1.07B 5.49%
2008-06-30 $0.10B $1.15B 8.98%
2008-03-31 $0.12B $1.18B 10.40%
2007-12-31 $0.17B $1.12B 16.13%
2007-09-30 $0.33B $1.14B 32.87%
2007-06-30 $0.36B $1.06B 40.97%
2007-03-31 $0.34B $0.97B 46.43%
2006-12-31 $0.22B $0.87B 35.25%
2006-09-30 $0.09B $0.58B 17.89%
2006-06-30 $0.02B $0.52B 4.55%
2006-03-31 $0.00B $0.50B 0.20%
2005-12-31 $0.03B $0.50B 6.10%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.542B $2.204B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $55.271B 9.49
Teva Pharmaceutical Industries (TEVA) Israel $24.090B 7.38
Mylan (MYL) United Kingdom $18.532B 7.63
Bausch Health Cos (BHC) Canada $9.165B 6.64
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.633B 4.39
Supernus Pharmaceuticals (SUPN) United States $2.334B 22.13
Amphastar Pharmaceuticals (AMPH) United States $0.971B 105.00
Akorn (AKRX) United States $0.845B 0.00
Homology Medicines (FIXX) United States $0.749B 0.00
CymaBay Therapeutics (CBAY) United States $0.624B 0.00
Assembly Biosciences (ASMB) United States $0.581B 0.00
Corium (CORI) United States $0.457B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.443B 0.00
Voyager Therapeutics (VYGR) United States $0.375B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.313B 0.00
Teligent (TLGT) United States $0.165B 0.00
Sol-Gel Technologies (SLGL) Israel $0.131B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.100B 0.00
Aevi Genomic Medicine (GNMX) United States $0.081B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.053B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Acasti Pharma (ACST) Canada $0.045B 0.00
Agile Therapeutics (AGRX) United States $0.031B 0.00
China Pharma Holdings (CPHI) China $0.013B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.009B 0.00